Ultrasound localization microscopy in the diagnosis of breast tumors and prediction of relevant histologic biomarkers associated with prognosis in humans: the protocol for a prospective, multicenter study

Abstract Background Benign and malignant breast tumors differ in their microvasculature morphology and distribution. Histologic biomarkers of malignant breast tumors are also correlated with the microvasculature. There is a lack of imaging technology for evaluating the microvasculature. Ultrasound l...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia Li, Lei Chen, Ronghui Wang, Jiang Zhu, Ao Li, Jianchun Li, Zhaojun Li, Wen Luo, Wenkun Bai, Tao Ying, Cong Wei, Di Sun, Yuanyi Zheng
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Medical Imaging
Subjects:
Online Access:https://doi.org/10.1186/s12880-024-01535-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544203103895552
author Jia Li
Lei Chen
Ronghui Wang
Jiang Zhu
Ao Li
Jianchun Li
Zhaojun Li
Wen Luo
Wenkun Bai
Tao Ying
Cong Wei
Di Sun
Yuanyi Zheng
author_facet Jia Li
Lei Chen
Ronghui Wang
Jiang Zhu
Ao Li
Jianchun Li
Zhaojun Li
Wen Luo
Wenkun Bai
Tao Ying
Cong Wei
Di Sun
Yuanyi Zheng
author_sort Jia Li
collection DOAJ
description Abstract Background Benign and malignant breast tumors differ in their microvasculature morphology and distribution. Histologic biomarkers of malignant breast tumors are also correlated with the microvasculature. There is a lack of imaging technology for evaluating the microvasculature. Ultrasound localization microscopy (ULM) can provide detailed microvascular architecture at super-resolution. The objective of this trial is to explore the role of ULM in distinguishing benign from malignant breast tumors and to explore the correlations between ULM qualitative and quantitative parameters and histologic biomarkers in malignant breast tumors. Methods/design This prospective and multicenter study will include 83 patients with breast tumors that will undergo ULM. 55 patients will be assigned to the malignant group, and 28 patients will be assigned to the benign group. The primary outcome is the differences in the qualitative parameters (microvasculature morphology, distribution, and flow direction) between benign and malignant breast tumors on ULM. Secondary outcomes include (1) differences in the quantitative parameters (microvasculature density, tortuosity, diameter, and flow velocity) between benign and malignant breast tumors based on ULM; (2) diagnostic performance of the qualitative parameters in distinguishing benign and malignant breast tumors; (3) diagnostic performance of the quantitative parameters in distinguishing benign and malignant breast tumors; (4) relationships between the qualitative parameters and histologic biomarkers in malignant breast tumors; (5) relationships between the quantitative parameters and histologic biomarkers in malignant breast tumors; and (6) the evaluation of inter-reader and intra-reader reproducibility. Discussion Detecting vascularity in breast tumors is of great significance to differentiate benign from malignant tumors and to predict histologic biomarkers. These histologic biomarkers, such as ER, PR, HER2 and Ki67, are closely related to prognosis evaluation. This trial will provide maximum information about the microvasculature of breast tumors and thereby will help with the formulation of subsequent differential diagnosis and the prediction of histologic biomarkers. Trial registration number/date Chinese Clinical Trial Registry ChiCTR2100048361/6th/July/2021. This study is a part of that clinical trial.
format Article
id doaj-art-8a3c7f04ef8247e8a95fa3ed44450cf4
institution Kabale University
issn 1471-2342
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Medical Imaging
spelling doaj-art-8a3c7f04ef8247e8a95fa3ed44450cf42025-01-12T12:44:45ZengBMCBMC Medical Imaging1471-23422025-01-012511810.1186/s12880-024-01535-7Ultrasound localization microscopy in the diagnosis of breast tumors and prediction of relevant histologic biomarkers associated with prognosis in humans: the protocol for a prospective, multicenter studyJia Li0Lei Chen1Ronghui Wang2Jiang Zhu3Ao Li4Jianchun Li5Zhaojun Li6Wen Luo7Wenkun Bai8Tao Ying9Cong Wei10Di Sun11Yuanyi Zheng12Department of Ultrasound in Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of MedicineDepartment of Ultrasound in Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of MedicineDepartment of Ultrasound, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Ultrasound, Women’s Hospital, Zhejiang University School of MedicineDepartment of Ultrasound, the First Affiliated Hospital of Nanjing Medical UniversityCancer Center, Department of Ultrasound Medicine, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical CollegeDepartment of Ultrasound, Shanghai General Hospital, Shanghai Jiaotong University School of MedicineDepartment of Ultrasound, Xijing Hospital, Fourth Military Medical UniversityDepartment of Ultrasound in Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of MedicineDepartment of Ultrasound in Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of MedicineDepartment of Ultrasound in Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of MedicineDepartment of Ultrasound in Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of MedicineDepartment of Ultrasound in Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of MedicineAbstract Background Benign and malignant breast tumors differ in their microvasculature morphology and distribution. Histologic biomarkers of malignant breast tumors are also correlated with the microvasculature. There is a lack of imaging technology for evaluating the microvasculature. Ultrasound localization microscopy (ULM) can provide detailed microvascular architecture at super-resolution. The objective of this trial is to explore the role of ULM in distinguishing benign from malignant breast tumors and to explore the correlations between ULM qualitative and quantitative parameters and histologic biomarkers in malignant breast tumors. Methods/design This prospective and multicenter study will include 83 patients with breast tumors that will undergo ULM. 55 patients will be assigned to the malignant group, and 28 patients will be assigned to the benign group. The primary outcome is the differences in the qualitative parameters (microvasculature morphology, distribution, and flow direction) between benign and malignant breast tumors on ULM. Secondary outcomes include (1) differences in the quantitative parameters (microvasculature density, tortuosity, diameter, and flow velocity) between benign and malignant breast tumors based on ULM; (2) diagnostic performance of the qualitative parameters in distinguishing benign and malignant breast tumors; (3) diagnostic performance of the quantitative parameters in distinguishing benign and malignant breast tumors; (4) relationships between the qualitative parameters and histologic biomarkers in malignant breast tumors; (5) relationships between the quantitative parameters and histologic biomarkers in malignant breast tumors; and (6) the evaluation of inter-reader and intra-reader reproducibility. Discussion Detecting vascularity in breast tumors is of great significance to differentiate benign from malignant tumors and to predict histologic biomarkers. These histologic biomarkers, such as ER, PR, HER2 and Ki67, are closely related to prognosis evaluation. This trial will provide maximum information about the microvasculature of breast tumors and thereby will help with the formulation of subsequent differential diagnosis and the prediction of histologic biomarkers. Trial registration number/date Chinese Clinical Trial Registry ChiCTR2100048361/6th/July/2021. This study is a part of that clinical trial.https://doi.org/10.1186/s12880-024-01535-7Breast tumorsUltrasound localization microscopyMicrovasculatureHistologic biomarkers
spellingShingle Jia Li
Lei Chen
Ronghui Wang
Jiang Zhu
Ao Li
Jianchun Li
Zhaojun Li
Wen Luo
Wenkun Bai
Tao Ying
Cong Wei
Di Sun
Yuanyi Zheng
Ultrasound localization microscopy in the diagnosis of breast tumors and prediction of relevant histologic biomarkers associated with prognosis in humans: the protocol for a prospective, multicenter study
BMC Medical Imaging
Breast tumors
Ultrasound localization microscopy
Microvasculature
Histologic biomarkers
title Ultrasound localization microscopy in the diagnosis of breast tumors and prediction of relevant histologic biomarkers associated with prognosis in humans: the protocol for a prospective, multicenter study
title_full Ultrasound localization microscopy in the diagnosis of breast tumors and prediction of relevant histologic biomarkers associated with prognosis in humans: the protocol for a prospective, multicenter study
title_fullStr Ultrasound localization microscopy in the diagnosis of breast tumors and prediction of relevant histologic biomarkers associated with prognosis in humans: the protocol for a prospective, multicenter study
title_full_unstemmed Ultrasound localization microscopy in the diagnosis of breast tumors and prediction of relevant histologic biomarkers associated with prognosis in humans: the protocol for a prospective, multicenter study
title_short Ultrasound localization microscopy in the diagnosis of breast tumors and prediction of relevant histologic biomarkers associated with prognosis in humans: the protocol for a prospective, multicenter study
title_sort ultrasound localization microscopy in the diagnosis of breast tumors and prediction of relevant histologic biomarkers associated with prognosis in humans the protocol for a prospective multicenter study
topic Breast tumors
Ultrasound localization microscopy
Microvasculature
Histologic biomarkers
url https://doi.org/10.1186/s12880-024-01535-7
work_keys_str_mv AT jiali ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT leichen ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT ronghuiwang ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT jiangzhu ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT aoli ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT jianchunli ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT zhaojunli ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT wenluo ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT wenkunbai ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT taoying ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT congwei ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT disun ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy
AT yuanyizheng ultrasoundlocalizationmicroscopyinthediagnosisofbreasttumorsandpredictionofrelevanthistologicbiomarkersassociatedwithprognosisinhumanstheprotocolforaprospectivemulticenterstudy